Heska earnings in line with Wall Street estimates, but foreshadow economic hit from COVID

LOVELAND — Veterinary diagnostic company Heska Corp. (Nasdaq: HSKA) met Wall Street’s expectations for revenue in the previous quarter, but the company expects to begin feeling the effects of COVID-19 economic crisis through the rest of the year.

Loveland-based Heska posted revenues of $30.65 million and a loss of 14 cents per share in the first quarter of the year, beating consensus analyst estimates by $280,000 but missing the per-share mark by a cent, according to data compiled by finance website Seeking Alpha.

Overall, Heska lost $5.3 million in the quarter.

The company’s revenue increased 3.9% from…